Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that Anecortave Acetate is as effective after
twelve months of treatment as photodynamic therapy (PDT) with Visudyne in patients eligible
for initial PDT treatment for wet age-related macular degeneration.